Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NewVale Capital is a growth equity investment firm founded in 2022, based in the United States. The firm specializes in investing in established life science services businesses that demonstrate proven revenue generation. NewVale Capital aims to support companies that are actively involved in the advancement of next-generation medicines, focusing on those with a strong track record of success.
The firm has a team of 11 members, including managing and executive partners, principals, and associates, all dedicated to identifying and nurturing growth opportunities within the life sciences sector. NewVale Capital's investment strategy is centered around partnering with businesses that not only show innovation but also have established revenue streams, ensuring a solid foundation for growth.
NewVale Capital concentrates on the services architecture of life sciences, specifically targeting businesses engaged in the development and delivery of next-generation medicines. The firm seeks to invest in companies that are not only innovative but also have a proven ability to generate revenue. This focus allows NewVale Capital to align its investments with businesses that are positioned for significant growth in the life sciences sector.
Investment criteria include a strong emphasis on established revenue streams and a commitment to advancing innovative medical solutions. NewVale Capital's geographic focus is primarily on the United States, where it aims to partner with companies that contribute to the life sciences landscape.
Todd Holmes - Managing Partner. Todd has extensive experience in venture capital and private equity, focusing on life sciences investments.
Patrick Lee - Executive Partner. Patrick has a background in healthcare investments and has led numerous successful funding rounds.
Rich Fante - Executive Partner. Rich brings expertise in operational management and strategic growth within the life sciences sector.
Sami Hawwa - Principal. Sami specializes in identifying high-potential investment opportunities in biotech.
Melanie Larkins - Principal. Melanie focuses on healthcare services and has a strong track record in growth equity.
Abigail Pohl Pierce - Vice President. Abigail has experience in operational support and strategic planning for portfolio companies.
Matt Galle - Associate. Matt assists in deal sourcing and due diligence processes.
Andra Stene - Vice President, Finance and Operations. Andra oversees financial operations and strategic initiatives.
Scott Waldman - Operating Partner. Scott provides operational insights and support to portfolio companies.
Anne Whitaker - Operating Partner. Anne focuses on strategic growth and operational efficiency within the firm.
Todd Smith - Operating Partner. Todd brings expertise in scaling life sciences businesses.
Founders can pitch to NewVale Capital through their website. It is advisable to include detailed information about the company's revenue, growth potential, and how it aligns with the firm's focus on life sciences. Response times may vary, so patience is recommended after submission.
What types of companies does NewVale Capital invest in?
NewVale Capital invests in established life science services businesses that demonstrate proven revenue generation and are involved in the development and delivery of next-generation medicines.
What is the investment stage focus of NewVale Capital?
The firm focuses on growth equity investments, targeting companies that are already generating revenue and have the potential for significant growth.
How can founders pitch to NewVale Capital?
Founders can submit their pitches through the NewVale Capital website. It is recommended to provide detailed information about the company's revenue generation and growth potential.
What geographic areas does NewVale Capital focus on?
NewVale Capital primarily invests in companies based in the United States, particularly those in the biotech and healthcare sectors.
What makes NewVale Capital different from other investors?
The firm emphasizes investing in proven, revenue-generating businesses within the life sciences sector, focusing on companies that contribute to innovative medical solutions.
What kind of support can portfolio companies expect from NewVale Capital?
NewVale Capital provides operational support and strategic guidance to its portfolio companies, leveraging its expertise in the life sciences sector to help them scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.